Drug recall · November 4, 2026
Formoterol Fumarate Inhalation Solution recall
Why: Failed Impurities/Degradation Specification
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC
- Lots / codes
Lot: 25BL0, Expires: 02/28/2027
- Quantity
- 3210 Cartons
- Company
- The Ritedose Corporation, Columbia, SC
- Distribution
- Nationwide within the U.S
- Initiated
- October 15, 2026 · Voluntary: Firm initiated
- Classified
- October 23, 2026
- Reported
- November 4, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Formoterol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.